How should I approach the management of a patient with SIADH who presents with mild hyponatremia?

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.

Posted: 17 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX

For a patient with syndrome of inappropriate antidiuretic hormone secretion (SIADH) presenting with mild hyponatremia (serum sodium concentration of 130–135 mmol/L), the management approach in General Practice should involve several key steps.

  • Initial Assessment and Monitoring: Ensure a repeat serum sodium measurement has been taken to rule out a rapidly decreasing serum sodium concentration, as this would necessitate immediate hospital admission . Asymptomatic, mild hyponatremia (130–135 mmol/L) may initially be managed in primary care .
  • Fluid Restriction: Fluid restriction is a recommended management strategy for people with SIADH .
  • Medication Review: Stop any non-essential medications that may be contributing to the hyponatremia, if appropriate, and recheck the serum sodium concentration after two weeks . If a contributing medication cannot be stopped, contact the appropriate specialist to discuss further management, monitoring, or referral .
  • Treat Underlying Causes: If an acute illness is contributing to the hyponatremia, treat the underlying problem and recheck the serum sodium concentration after two weeks or sooner based on clinical judgment .
  • Referral Considerations:
    • Discuss with an endocrinologist about the need for admission or referral if the person has asymptomatic, moderate hyponatremia (serum sodium concentration of 125–129 mmol/L) .
    • Refer to an endocrinologist if SIADH or another endocrine cause is suspected, with the urgency depending on clinical judgment . Specialist input is required to confirm the diagnosis and initiate treatment for hyponatremia related to an endocrine disorder .
    • Arrange an urgent 2-week wait referral to the appropriate specialist if malignant disease is suspected as an underlying cause of SIADH .
    • Tolvaptan, a medication for hyponatremia secondary to SIADH, should only be initiated in hospital or under specialist supervision .

Educational content only. Always verify information and use clinical judgement.